Clinical Trials Logo

Clinical Trial Summary

In this study, we aim to evaluate the feasibility of anti-PSMA labelling to detect post-operative prostatic tissues by two ex vivo fluorescence techniques. We will evaluate the feasibility and detection of anti-PSMA labelling by:

1. / the FEMTO-ST institute medical device,

2. / the confocal microscope that will be used to measure fluorescence spectra of biological samples.


Clinical Trial Description

For this protocol, 12 patients will be included. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03157856
Study type Observational
Source University Hospital, Grenoble
Contact
Status Terminated
Phase
Start date May 11, 2017
Completion date January 8, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06152419 - Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project N/A
Active, not recruiting NCT05410002 - Diet Effect on Cancer Treatment Outcome Phase 1
Completed NCT04836221 - Comorbidities And Reducing inEquitieS N/A
Not yet recruiting NCT06035731 - Evaluation of the Medical Service by Socio-aesthetics in Oncology N/A
Not yet recruiting NCT05154474 - Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
Active, not recruiting NCT06359717 - Prospective Validation of PSMA-RADS
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Completed NCT00172055 - Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy Phase 3
Completed NCT04074460 - Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study Phase 4
Completed NCT03866785 - Physical Activity Experiment on Male Prostate Cancer Patients N/A